| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |